期刊的影响因子--文章列表

期刊文章列表
Ying Deng，Zhaowei Sun，Lei Wang，Minghui Wang，Jie Yang，Genxi Li（State Key Laboratory of Pharmaceutical Biotechnology，School of Life Sciences，Nanjing University）.Biosensor-based assay of exosome biomarker for early diagnosis of cancer[J].医学前沿(英文版),2022,第2期 Yi Zhang¹，Haocheng Zhang¹，Wenhong Zhang^1,2（Department of Infectious Diseases，National Medical Center for Infectious Diseases，Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response，Huashan Hospital，Fudan University；State Key Laboratory of Genetic Engineering and Institute of Biostatistics，School of Life Sciences，Fudan University）.SARS-CoV-2 variants,immune escape,and countermeasures[J].医学前沿(英文版),2022,第2期 Haoran Wei¹，Mingming Zhao^2,3，Man Huang¹，Chenze Li^1,4，Jianing Gao³，Ting Yu¹，Qi Zhang³，Xiaoqing Shen¹，Liang Ji³，Li Ni¹，Chunxia Zhao¹，Zeneng Wang⁵，Erdan Dong^2,3，Lemin Zheng³，Dao Wen Wang¹（Division of Cardiology，Department of Internal Medicine，Tongji Hospital，Tongji Medical College，Huazhong University of Science &Technology and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders；Department of Cardiology and Institute of Vascular Medicine，Peking University Third Hospital，NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides，Beijing Key Laboratory of Cardiovascular Receptors Research；The Institute of Cardiovascular Sciences，Peking University，Key Laboratory of Molecular Cardiovascular Science，Ministry of Education；Department of Cardiology，Zhongnan Hospital of Wuhan University；Department of Cellular and Molecular Medicine，Lerner Research Institute，Cleveland Clinic）.FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction：evidence from an Asian population[J].Frontiers of Medicine,2022,第2期 Yiming Shao^1,2，Yingqi Wu¹，Yi Feng¹，Wenxin Xu³，Feng Xiong⁴，Xinxin Zhang³（Chinese Center for Disease Control and Prevention；Changping Laboratory；Department of Infectious Diseases，Research Laboratory of Clinical Virology National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Department of Policy Science，Central Committee of the Chinese Peasants and Workers Democratic Party）.SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic[J].医学前沿(英文版),2022,第2期 Lili Chen¹，Ling Xi²，Jie Jiang³，Rutie Yin^4,5，Pengpeng Qu⁶，Xiuqin Li⁷，Xiaoyun Wan¹，Yaxia Chen¹，Dongxiao Hu¹，Yuyan Mao¹，Zimin Pan¹，Xiaodong Cheng¹，Xinyu Wang¹，Qingli Li^4,5，Danhui Weng²，Xi Zhang³，Hong Zhang⁶，Quanhong Ping⁶，Xiaomei Liu⁷，Xing Xie¹，Beihua Kong³，Ding Ma²，Weiguo Lu¹（Department of Gynecological Oncology Women's Hospital，Zhejiang University School of Medicine；Department of Obstetrics and Gynecology，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Obstetrics and Gynecology，Qilu Hospital of Shandong University；Department of Obstetrics and Gynecology West China Second University Hospital of Sichuan University；Key Laboratory of Birth Defects and Related Disease of Women and Children(Sichuan University)，Ministry of Education；Tianjin Central Hospital of Gynecology Obstetrics；Shengjing Hospital of China Medical University）.Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia：a multi-centric randomized clinical trial[J].医学前沿(英文版),2022,第2期 Xiaoguang Xu¹，Wei Zhang^1,2，Mingquan Guo³，Chenlu Xiao⁴，Ziyu Fu¹，Shuting Yu¹，Lu Jiang¹，Shengyue Wang¹，Yun Ling³，Feng Liu¹，Yun Tan¹，Saijuan Chen¹（Shanghai Institute of Hematology，State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；School of Life Sciences and Biotechnology Shanghai Jiao Tong University；Shanghai Public Health Clinical Center；Department of Laboratory Medicine，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine）.Integrated analysis of gut microbiome and host immune responses in COVID-19[J].医学前沿(英文版),2022,第2期 Wei Zhang^1,2，Xiaoguang Xu¹，Ziyu Fu¹，Jian Chen³，Saijuan Chen¹，Yun Tan¹（Shanghai Institute of Hematology State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；School of Life Sciences and Biotechnology，Shanghai Jiao Tong University；Department of Thoracic Surgery，Shanghai Pulmonary Hospital，Tongji University School of Medicine）.PathogenTrack and Yeskit：tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19[J].医学前沿(英文版),2022,第2期 Yan Kong¹，Huanhuan Hu¹，Yangyang Shan¹，Zhen Zhou¹，Ke Zen¹，Yulu Sun²，Rong Yang³，Zheng Fu¹，Xi Chen^1,4（Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy，State Key Laboratory of Pharmaceutical Biotechnology，Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology，NJU Advanced Institute of Life Sciences(NAILS)，Institute of Artificial Intelligence Biomedicine，School of Life Sciences，Nanjing University；Department of General Surgery，Drum Tower Hospital，Medical school of Nanjing University；Department of Urology，Drum Tower Hospital，Medical School of Nanjing University，Institute of Urology，Nanjing University；Research Unit of Extracellular RNA，Chinese Academy of Medical Sciences）.Accurate quantification of 3'-terminal 2'-O-methylated small RNAs by utilizing oxidative deep sequencing and stem-loop RT-qPCR[J].医学前沿,2022,第2期 Lei Fan，Li Wang，Lei Cao，Huayuan Zhu，Wei Xu，Jianyong Li（Department of Hematology，Pukou CLL Center，Jiangsu Province Hospital，The First Affiliated Hospital of Nanjing Medical University）.Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse large B-cell lymphoma in Chinese patients[J].医学前沿(英文版),2022,第2期 Xin Yin，Azhar Anwar，Yanbo Wang，Huanhuan Hu，Gaoli Liang，Chenyu Zhang（Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy，State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology，Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology，NJU Advanced Institute of Life Sciences(NAILS)，School of Life Sciences，Nanjing University）.Paternal environmental exposure-induced spermatozoal small noncoding RNA alteration meditates the intergenerational epigenetic inheritance of multiple diseases[J].医学前沿(英文版),2022,第2期 Xinyue Zhao¹，Keqiang Liu¹，Wenshuai Xu²，Meng Xiao¹，Qianli Zhang¹，Jiaxing Song¹，Keqi Chen²，Yaping Liu¹，Xinlun Tian²，Kai-Feng Xu²，Xue Zhang¹（McKusick-Zhang Center for Genetic Medicine，State Key Laboratory of Medical Molecular Biology Institute of Basic Medical Sciences，Chinese Academy of Medical Sciences & Peking Union Medical College；Department of Pulmonary and Critical Care Medicine，Peking Union Medical College Hospital，Chinese Academy of Medical Sciences & Peking Union Medical College）.Novel mutation c.1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis[J].医学前沿(英文版),2022,第1期 Chuanqi Liu^1,2，Ming Pei³，Qingfeng Li²，Yuanyuan Zhang⁴（Department of Plastic and Burn Surgery，West China Hospital，Sichuan University；Department of Plastic and Reconstructive Surgery，Shanghai Ninth People's Hospital，Shanghai Jiao Tong University School of Medicine；Stem Cell and Tissue Engineering Laboratory，Department of Orthopaedics，West Virginia University；Wake Forest Institute for Regenerative Medicine，Wake Forest University Health Sciences）.Decellularized extracellular matrix mediates tissue construction and regeneration[J].医学前沿(英文版),2022,第1期 Jing Wang¹，Zequn Lu²，Meng Jin³，Ying Wang⁴，Kunming Tian^5,6，Jun Xiao¹，Yimin Cai²，Yanan Wang¹，Xu Zhang⁷，Tao Chen⁸，Zhi Yao⁹，Chunguang Yang¹，Renli Deng¹⁰，Qiang Zhong¹¹，Xiongbo Deng¹²，Xin Chen¹³，Xiang-ping Yang¹⁴，Gonghong Wei¹⁵，Zhihua Wang¹，Jianbo Tian²，Xiao-ping Chen¹⁶（Department of Urology，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Epidemiology and Biostatistics，Key Laboratory for Environment and Health，School of Public Health，Tongji Medical College，Huazhong University of Science and Technology；Department of Respiratory and Critical Care Medicine，Renmin Hospital of Wuhan University；Department of Virology，Wuhan Centers for Disease Prevention and Control；Institute of Reproductive Health，Tongji Medical College，Huazhong University of Science and Technology；School of Nursing，Zunyi Medical University；Key Laboratory of Environment and Health，Ministry of Education & Ministry of Environmental Protection，State Key Laboratory of Environmental Health(Incubating)，School of Public Health，Tongji Medical College，Huazhong University of Science and Technology；Department and Institute of Infectious Disease，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Respirology and Tuberculosis Specialty，Wuhan Pulmonary Hospital；The Fifth Affiliated(Zhuhai) Hospital of Zunyi Medical University；Department of Critical Care Medicine，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Radiology，Wuhan Jinyintan Hospital；Department of Oncology，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Immunology，Tongji Medical College，Huazhong University of Science and Technology；Biocenter Oulu，Faculty of Biochemistry and Molecular Medicine，University of Oulu；Hepatic Surgery Center，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology）.Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B：a multi-center retrospective cohort study[J].医学前沿(英文版),2022,第1期 Qiaoli Shi¹，Fei Xia¹，Qixin Wang¹，Fulong Liao¹，Qiuyan Guo¹，Chengchao Xu^1,2，Jigang Wang^1,3,4,2（Artemisinin Research Center，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Department of Geriatrics，The Second Clinical Medical College of Jinan University，The First Affiliated Hospital of Southern University of Science and Technology，Shenzhen People's Hospital；Central People's Hospital of Zhanjiang；Guangdong Provincial Key Laboratoty of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University）.Discovery and repurposing of artemisinin[J].医学前沿(英文版),2022,第1期 Yuntao Zhang¹，Yunkai Yang¹，Niu Qiao²，Xuewei Wang¹，Ling Ding³，Xiujuan Zhu³，Yu Liang⁴，Zibo Han⁴，Feng Liu²，Xinxin Zhang⁵，Xiaoming Yang¹（China National Biotec Group Company Limited；Shanghai Institute of Hematology，State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Beijing Institute of Biological Products，China National Biotec Group Company Limited；National Vaccine and Serum Institute，China National Biotec Group Company Limited；Department of Infectious Diseases，Research Laboratory of Clinical Virology Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine）.Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults[J].医学前沿(英文版),2022,第1期 Jiabing Zhan，Chen Chen，Dao Wen Wang，Huaping Li（Division of Cardiology Department of Internal Medicine，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders）.Hyperglycemic memory in diabetic cardiomyopathy[J].医学前沿(英文版),2022,第1期 Fang Huang¹，Yanwen Cui¹，He Yan¹，Hui Liu²，Xiangrui Guo³，Guangze Wang⁴，Shuisen Zhou¹，Zhigui Xia¹（National Institute of Parasitic Diseases，Chinese Center for Disease Control and Prevention，Chinese Center for Tropical Diseases Research，WHO Collaborating Center for Tropical Diseases，National Centre for International Research on Tropical Diseases，NHC Key Laboratory of Parasite and Vector Biology (National Institute of Parasitic Diseases，Chinese Center for Disease Control and Prevention)；Yunnan Institute of Parasitic Diseases；Yingjiang County for Disease Control and Prevention；Hainan Center for Disease Control & Prevention）.Prevalence of antifolate drug resistance markers in Plasmodium vivax in China[J].医学前沿(英文版),2022,第1期 Jianhai Yin，Mei Li，He Yan，Shuisen Zhou，Zhigui Xia（National Institute of Parasitic Diseases，Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research)，NHC Key Laboratory of Parasite and Vector Biology，WHO Collaborating Center for Tropical Diseases，National Center for International Research on Tropical Diseases）.Laboratory diagnosis for malaria in the elimination phase in China：efforts and challenges[J].医学前沿(英文版),2022,第1期 Chun Cai，Yuexing Liu，Yanyun Li，Yan Shi，Haidong Zou，Yuqian Bao，Yun Shen，Xin Cui，Chen Fu，Weiping Jia（Shanghai Diabetes Institute，Shanghai Jiao Tong University Affiliated Sixth People's Hospital，National Office for Primary Diabetes Care，Shanghai Technical Center for Diabetes Prevention and Clinical Care，Shanghai Key Laboratory of Diabetes Mellitus，Department of Endocrinology and Metabolism，Shanghai Clinical Center for Diabetes，Shanghai Key Clinical Center for Metabolic Disease；Shanghai Municipal Center for Disease Control & Prevention；Shanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital，Shanghai Key Laboratory of Ocular Fundus Diseases，Shanghai General Hospital，Shanghai Engineering Center for Visual Science and Photomedicine；Shanghai Municipal Health Commission Information Center；the SIM Study Group）.Effectiveness of quality of care for patients with type 2 diabetes in China：findings from the Shanghai Integration Model(SIM)[J].医学前沿(英文版),2022,第1期 Huai-yu Wang¹，Suyuan Peng¹，Zhanghui Ye²，Pengfei Li²，Qing Li²，Xuanyu Shi¹，Rui Zeng³，Ying Yao⁴，Fan He³，Junhua Li³，Liu Liu³，Shuwang Ge³，Xianjun Ke⁵，Zhibin Zhou⁵，Gang Xu³，Ming-hui Zhao^6,7，Haibo Wang⁸，Luxia Zhang^1,2,6，Erdan Dong⁹（National Institute of Health Data Science at Peking University；Peking University Advanced Institute of lnformation Technology；Department of Nephrology，Tongji Hospital，Tongji Medical College，Huazhong Universiry of Science and Technology；Department of Clinical Nutrition，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Taikang Tongji(Wuhan) Hospital；Renal Division，Department of Medicine，Peking University First Hospital，Peking University Institute of Nephrology；Peking-Tsinghua Center for Life Sciences；First Affiliated Hospital of Sun Yat-sen University；Department of Cardiology and Institute of Vascular Medicine，Peking University Third Hospital，Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides，Ministry of Health，Key Laboratory of Molecular Cardiovascular Sciences，Ministry of Education，Beijing Key Laboratory of Cardiovascular Receptors Research）.Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension[J].医学前沿(英文版),2022,第1期 Sisi Wang^1,2，Lijun Peng^1,2，Wenqian Xu^1,2，Yuebo Zhou^1,2，Ziyan Zhu³，Yushan Kong⁴，Stewart Leung⁴，Jin Wang^1,2，Xiaoqiang Yan⁴，Jian-Qing Mi^1,2（Shanghai Institute of Hematology，State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；P?le Franco-Chinois de Recherche en Sciences du Vivant et Genomique；Shanghai Blood Center；Generon Biomed）.Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia：targeted immunotherapy for acute lymphoblastic leukemia[J].医学前沿(英文版),2022,第1期 Zehong Huang，Yingying Su，Tianying Zhang，Ningshao Xia（State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics，National Institute of Diagnostics and Vaccine Development in Infectious Diseases，Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics，School of Public Health，Xiamen University）.A review of the safety and efficacy of current COVID-19 vaccines[J].医学前沿(英文版),2022,第1期 Yalin Liu¹，Xianghang Luo²（Department of Endocrinology，Endocrinology Research Center，Xiangya Hospital of Central South University；National Clinical Research Center for Geriatric Disorders，Xiangya Hospital of Central South University）.New practice in semaglutide on type-2 diabetes and obesity：clinical evidence and expectation[J].医学前沿(英文版),2022,第1期首页上一页 1 2 3 尾页共有3页，转到页

期刊文章列表